There are different molecular subtypes of breast cancer, defined by hormone receptor expression status (Estrogen receptor; ER, and Progesterone receptor; PR) and Human epidermal growth factor receptor 2 (HER2) status, affecting prognosis2,3. This evidence concerns the gene ERBB2 and breast cancer.